Medical Marijuana and the Limits of Federal Permission

Your local hookah lounge gained no federal permission to serve recreational marijuana from the April rule to reschedule it. The government moved FDA-approved marijuana products and marijuana covered by qualifying state medical licenses into Schedule III. The new medical pathway expressly excludes nonmedical manufacture, distribution, dispensing, and use.¹

What the courts decided

On September 9, the D.C. Circuit declined to pause the rule while the challenge proceeds. The panel found that the challengers had not met the requirements for temporary relief. It did not decide the rule’s legality or dismiss the case for lack of standing.²

The National Drug and Alcohol Screening Association and three MMJ companies argued that the government improperly bypassed ordinary scheduling procedures by invoking treaty obligations. Relying on the 1977 NORML decision, they maintained that choosing among treaty-compliant classifications required the ordinary process. They also challenged related regulatory amendments adopted without public comment and alleged financial and public health harms from allowing the rule to operate during the review. These remain the challengers’ arguments.³

The Sixth Circuit addressed a different dispute on September 10. In Hello Farms, it rejected enforcement of a marijuana supply contract underlying a $31.8 million jury award. The April change did not retroactively validate the agreement, and the court explained that the parties still needed the required DEA registration for an otherwise comparable medical transaction.⁴

What businesses still need

Federal classification and permission to market a drug answer different questions. FDA approval generally remains necessary before introducing a new drug into interstate commerce, unless an applicable exception permits the activity. Congress separately provides for investigational use under prescribed conditions. A state license or authorization to handle controlled substances does not replace those requirements.⁵

The special medical pathway also remains tied to state authority. A federal registration cannot exceed the underlying license’s scope and automatically stops when that license expires, is revoked, or is suspended. Qualifying state medical certifications may support dispensing under the rule’s specified conditions. None of those provisions authorizes recreational service.⁶

Where state restrictions fit

The federal change does not erase state drug laws. Congress preserved them unless a positive conflict prevents both laws from operating together. A particular prohibition still requires review of its text and other applicable federal law.⁷

Favoring local businesses presents a separate constitutional question. The First Circuit invalidated Maine’s residency requirement for medical dispensary officers and directors despite the federal prohibition then in force.⁸

The Ninth Circuit reached the opposite conclusion about Commerce Clause protection for a federally prohibited market. Those differing approaches predate the April change; neither supplies a blanket answer for every restriction under the new framework.⁹

What it all means

A business must satisfy all applicable federal and state requirements before lawfully supplying marijuana. The April rule permits specified medical activities under its registration framework and expressly excludes recreational distribution and use. It gives a hookah lounge no federal permission to serve marijuana recreationally.¹⁰

FDA approval generally remains necessary before introducing a new marijuana drug into interstate commerce, unless an applicable exception permits the activity. DEA registration does not replace that requirement. Investigational access carries separate safeguards and does not authorize ordinary commercial sales.¹¹

State restrictions also remain independently relevant. Federal rescheduling alone does not override a state prohibition, although any particular restriction remains subject to applicable federal statutory and constitutional limits. Businesses must establish authority to operate where they intend to sell or dispense the product.¹²

Review other pharmacy-law analyses or explore the capabilities and research topics.